Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants

Trung Tran(Oslo University Hospital), Fridtjof Lund‐Johansen(Oslo University Hospital), Lill Trogstad(Norwegian Institute of Public Health), Per Magnus(Norwegian Institute of Public Health), Knut E. A. Lundin(Oslo University Hospital), Anders Åsberg(Oslo University Hospital), Fredrik Müller(Oslo University Hospital), Jan Terje Andersen(Oslo University Hospital), Kristine Thomassen(Oslo University Hospital), Adity Chopra(Oslo University Hospital), Aina Karen Anthi(Oslo University Hospital), Lisa Tietze(Oslo University Hospital), John Torgils Vaage(University of Oslo), Andreas Lind(Oslo University Hospital), Marton König(Oslo University Hospital), Marte Lie Høivik(Oslo University Hospital), Gro Owren Nygaard(Anna Needs Neuroblastoma Answers), Karsten Midtvedt(Oslo University Hospital), Kristine Wiencke(Oslo University Hospital), Gunnveig Grødeland(Oslo University Hospital), Espen Melum(Oslo University Hospital), Lise Sofie Haug Nissen‐Meyer(World Health Organization Regional Office for South-East Asia), Reidun Dahle(Oslo University Hospital), Asle W. Medhus(Oslo University Hospital), Karin Danielsson(Oslo University Hospital), Eline Benno Vaage(Oslo University Hospital), Anette Kolderup(Oslo University Hospital), Jan Cato Holter(Oslo University Hospital), Tone Lise Åvitsland(Oslo University Hospital), Grete Birkeland Kro(Oslo University Hospital), Ludvig A. Munthe(Oslo University Hospital), Rebecca Jane Cox(Haukeland University Hospital), Siri Mjaaland(Norwegian Institute of Public Health), Pål Aukrust(University of Oslo), Andreas Barratt‐Due(Oslo University Hospital), Nina Langeland(Norwegian Institute of Public Health), Randi Fuglaas Karlsen(Oslo University Hospital), Fan Zhou(University of Pittsburgh), Adi Mehta(Oslo University Hospital), Arne Søraas(Oslo University Hospital)
npj Vaccines
December 30, 2022
Cited by 44


Related Papers